Analyst Ratings January 23, 2026

TD Cowen Elevates Price Target for Atlantic Union Bankshares on Robust Earnings Trajectory

Strong Q4 results and optimistic growth forecasts bolster Buy rating and price outlook

By Sofia Navarro AUB
TD Cowen Elevates Price Target for Atlantic Union Bankshares on Robust Earnings Trajectory
AUB

TD Cowen has raised its price target for Atlantic Union Bankshares to $46.00 from $45.00, maintaining a Buy rating, following the bank's impressive fourth-quarter 2025 performance. The company's earnings per share and revenue both surpassed expectations, reinforcing confidence in its organic growth potential and financial stability through 2026 and beyond.

Key Points

  • TD Cowen increased Atlantic Union Bankshares’ price target to $46.00 while maintaining a Buy rating due to strong Q4 2025 earnings.
  • Atlantic Union exceeded earnings forecasts with $0.97 EPS and revenue of $391.79 million, outperforming analyst expectations.
  • Projections for 2026 include 15% EPS growth and 13% growth in tangible book value, reflecting robust organic growth potential.

TD Cowen has adjusted its price target for Atlantic Union Bankshares (NYSE:AUB) upward to $46.00, an increase from the prior $45.00 target, while sustaining its Buy rating on the stock. Currently, Atlantic Union shares trade at $39.67. Analyst price targets on the stock vary between $38 and $50 as per the data from InvestingPro.

This revision was prompted by Atlantic Union Bankshares’ release of its fourth-quarter 2025 core earnings per share (EPS) of $0.97, a figure that outperformed prevailing market expectations. The bank’s strong revenue performance alongside reduced provisioning expenses contributed to these results. Over the past twelve months, Atlantic Union has maintained consistent profitability, reporting a basic EPS of $2.03.

Analyst Janet Lee from TD Cowen highlighted that the quarterly outcomes solidify the bank's position for what she describes as “its next leg of strong organic growth and inflection point.” The firm projects Atlantic Union will achieve approximately 15% EPS growth and a 13% increase in tangible book value in 2026, indicating a robust outlook for the bank’s financial development.

TD Cowen also-mentioned that Atlantic Union’s execution aligns well with the company’s stated strategy and investor day commitments. They see significant upside potential for the stock, which is currently valued at about 9.5 times the forecasted earnings for 2027, suggesting a favorable entry point for investors.

Complementing this, Atlantic Union Bankshares reported fourth-quarter 2025 earnings that exceeded analyst predictions, posting $0.97 EPS compared to the $0.86 forecast, a positive surprise of approximately 12.79%. The bank's revenues for the same quarter reached $391.79 million, surpassing the anticipated $379.01 million. These figures underscore the company’s stronger-than-expected financial results and reflect positively on its current operational momentum.

Given these encouraging earnings and revenue figures, Atlantic Union’s recent performance may influence upcoming analyst ratings and investor outlooks. The company's advances further demonstrate sound financial health, which is crucial for prospective growth in an evolving banking sector.

Risks

  • The forecasts depend on Atlantic Union sustaining revenue growth and controlling provision expenses, which may fluctuate with economic conditions.
  • Stock valuation at roughly 9.5 times projected 2027 EPS could be subject to market volatility impacting price-to-earnings multiples.
  • Future analyst ratings and stock performance may be influenced by unforeseen changes in the banking sector or company execution.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026